Search Results

Richard Ellis

I am a Director within the Clearwater Growth team. I joined Clearwater in 2014 having previously worked at BDO where I qualified as a Chartered Accountant. I’m a deal leader with a focus on TMT and have advised on a number of deals in the sector including Palatine Impact’s investment in e-days Absence Management and the sale of Union Square to Deltek Inc. I’ve also advised on a number of high-profile transactions outside of TMT including the sale of Westleigh to listed Countryside Properties plc and Sidhil to US corporate, Drive DeVilbiss.

At Clearwater, I've had the opportunity to advise on a wide variety of transactions and a range of clients, including owner-managers, institutional investors and large corporates, ensuring no two days are the same. A significant amount of effort and work goes into every transaction, often with numerous ups and downs along the way. It is often a life-changing event for our client so the feeling you get from completing a deal is a real highlight. 

I had the privilege of being awarded Young Dealmaker of the Year at the East Midlands Dealmakers Awards in 2018. 

Louise Hooper

I joined Clearwater over nine years ago and am currently part of our deal team working primarily on growth transactions. I’ve advised on a range of both trade and PE deals, across a number of sectors including Healthcare, Consumer, Business Services, and Industrials.

Arturo Polesello Gregorini

After graduating with honours in Business Economics and Management at Università Cattolica del Sacro Cuore and then earning a Master's degree in Finance with a specialisation in Quantitative Finance in France, I gained brief experience in the CIB division of Deutsche Bank in Milan. Since June 2023, I have been working as an Analyst at Clearwater, where I am actively involved in M&A transactions daily, both on the buy-side and sell-side, for entrepreneurs and private equity funds, as well as in Debt Advisory activities. Interacting daily with various counterparts, I am proactively involved in transactions through process management and providing support in identifying the most suitable strategic and financial choices for the client and their needs.

Stefan Sachsenhauser

As a member of the German management team, I am responsible for the Life Sciences & Healthcare sector in the DACH region. I support entrepreneurs and financial investors in the realisation of buy- and sell-side corporate transactions in the pharmaceutical, medical technology, health tech, and provider care sectors. Before joining Clearwater, I worked for KPMG and Ernst & Young in the area of Corporate Finance, Strategy and Transactions. In addition to my business degree, I am a certified accountant (IHK). As a passionate Bavarian and a true Munich native, I love the city and its enchanting Alpine foothills. I do a lot of sports in my spare time as a footballer, skier, and golfer. I also enjoy travelling to Italy, Spain, and Argentina.

Will Arnold

I am a Director in our Healthcare team and have spent my entire career working in Healthcare and Life Sciences M&A, advising private equity clients, publicly traded companies and privately owned companies on a broad range of domestic and cross-border transactions.

Mark Gillingham

I am currently a Director at Clearwater, where I have spent the last 10+ years. I have over 14 years of experience in the sector, previously working at EY. I specialise in Industrials & Chemicals transactions, with a particular focus on the Mobility and Energy Transition sectors.

Sarah Taylor

I am a Business Services Partner at Clearwater and lead the Midlands team. I have been transacting in deals for nearly 30 years, focused on advising entrepreneurs, founders, and private equity clients. Since joining Clearwater in 2021, I have developed specific expertise in the professional services sector.

Sébastien Allegot

I joined Clearwater in 2017 and have worked across the industrials & chemicals, healthcare and real estate sectors. A personal highlight of mine was working on the acquisition by MBO Partenaires of BCF Life Sciences from Céréa Partenaires and Sodero Gestion in 2018. During this transaction our team was able to help our client reach a successful outcome in a competitive process. I was attracted to joining Clearwater because of its reputation in mid-market transactions and its multi-sector expertise, while joining a growing business was another strong reason for my choice. Prior to joining Clearwater I worked in M&A at Degroof Petercam in Paris after graduating with a MSc in Corporate Finance from ESCP, and from ECE Paris with a major in Financial Engineering.

Korantin Hénaff Le Gall

I joined the Clearwater team in Paris in March 2022 as an Analyst. After initial experiences in Transaction Services at EY and in M&A in a French multinational specialized in restaurants, I joined the small and mid-cap M&A team of KPMG Corporate Finance for two years, where I carried out transactions in the industry, technology, healthcare as well as wine and spirits sectors. I chose to join Clearwater for its reputation, its multi-sector expertise and the opportunity to work closely with the management of the companies we support. This demanding and stimulating environment allows me to develop my skills on various subjects within a benevolent and dynamic team. I have a master’s degree in Finance from the University of Paris I Panthéon Sorbonne.